A detailed history of Cerity Partners LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Cerity Partners LLC holds 711,882 shares of BSX stock, worth $64.2 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
711,882
Previous 631,548 12.72%
Holding current value
$64.2 Million
Previous $48.6 Million 22.66%
% of portfolio
0.13%
Previous 0.13%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$72.96 - $84.0 $5.86 Million - $6.75 Million
80,334 Added 12.72%
711,882 $59.7 Million
Q2 2024

Aug 13, 2024

SELL
$67.33 - $77.71 $2.1 Million - $2.43 Million
-31,219 Reduced 4.71%
631,548 $48.6 Million
Q1 2024

May 14, 2024

BUY
$57.6 - $68.62 $6.41 Million - $7.64 Million
111,346 Added 20.19%
662,767 $45.4 Million
Q4 2023

Jan 26, 2024

BUY
$48.64 - $57.81 $7.07 Million - $8.4 Million
145,359 Added 35.8%
551,421 $31.9 Million
Q3 2023

Nov 13, 2023

SELL
$50.19 - $54.68 $3.77 Million - $4.1 Million
-75,018 Reduced 15.59%
406,062 $21.4 Million
Q2 2023

Aug 14, 2023

BUY
$49.72 - $54.64 $334,715 - $367,836
6,732 Added 1.42%
481,080 $26 Million
Q1 2023

May 11, 2023

BUY
$45.09 - $50.03 $1.17 Million - $1.3 Million
25,967 Added 5.79%
474,348 $23.7 Million
Q4 2022

Feb 15, 2023

BUY
$39.56 - $47.22 $1.3 Million - $1.55 Million
32,904 Added 7.92%
448,381 $20.8 Million
Q3 2022

Nov 10, 2022

BUY
$36.71 - $109.66 $29,918 - $89,372
815 Added 0.2%
415,477 $16.1 Million
Q2 2022

Aug 10, 2022

BUY
$35.24 - $47.1 $11.4 Million - $15.3 Million
324,804 Added 361.46%
414,662 $15.5 Million
Q1 2022

Apr 25, 2022

SELL
$40.9 - $45.1 $128,466 - $141,659
-3,141 Reduced 3.38%
89,858 $3.98 Million
Q4 2021

Feb 14, 2022

BUY
$38.07 - $44.87 $324,013 - $381,888
8,511 Added 10.07%
92,999 $3.95 Million
Q3 2021

Oct 25, 2021

SELL
$41.23 - $45.88 $135,316 - $150,578
-3,282 Reduced 3.74%
84,488 $3.67 Million
Q2 2021

Aug 11, 2021

SELL
$38.58 - $44.24 $1.57 Million - $1.8 Million
-40,731 Reduced 31.7%
87,770 $3.75 Million
Q1 2021

Aug 11, 2021

SELL
$35.27 - $39.67 $20,103 - $22,611
-570 Reduced 0.44%
128,501 $4.97 Million
Q1 2021

May 12, 2021

SELL
$35.27 - $39.67 $600,577 - $675,500
-17,028 Reduced 11.66%
129,071 $4.99 Million
Q4 2020

Feb 11, 2021

BUY
$33.15 - $41.97 $335,511 - $424,778
10,121 Added 7.44%
146,099 $5.25 Million
Q3 2020

Nov 12, 2020

BUY
$34.44 - $42.23 $3.1 Million - $3.8 Million
90,010 Added 195.81%
135,978 $5.2 Million
Q2 2020

Aug 14, 2020

BUY
$30.19 - $39.11 $91,807 - $118,933
3,041 Added 7.08%
45,968 $1.61 Million
Q1 2020

May 14, 2020

BUY
$25.83 - $45.71 $295,960 - $523,745
11,458 Added 36.41%
42,927 $1.4 Million
Q4 2019

Feb 14, 2020

SELL
$37.87 - $45.37 $2.5 Million - $3 Million
-66,130 Reduced 67.76%
31,469 $1.42 Million
Q3 2019

Oct 30, 2019

BUY
$40.31 - $43.45 $1.58 Million - $1.7 Million
39,233 Added 67.22%
97,599 $3.97 Million
Q2 2019

Aug 14, 2019

SELL
$34.91 - $42.98 $668,770 - $823,367
-19,157 Reduced 24.71%
58,366 $2.51 Million
Q1 2019

May 14, 2019

SELL
$32.91 - $40.75 $1.59 Million - $1.96 Million
-48,217 Reduced 38.35%
77,523 $2.98 Million
Q4 2018

Feb 06, 2019

BUY
$31.73 - $39.04 $210,750 - $259,303
6,642 Added 5.58%
125,740 $4.44 Million
Q3 2018

Nov 15, 2018

SELL
$32.83 - $38.63 $180,729 - $212,658
-5,505 Reduced 4.42%
119,098 $4.59 Million
Q2 2018

Aug 15, 2018

SELL
$26.84 - $34.32 $186,564 - $238,558
-6,951 Reduced 5.28%
124,603 $4.08 Million
Q1 2018

May 15, 2018

SELL
$25.2 - $28.54 $194,090 - $219,815
-7,702 Reduced 5.53%
131,554 $3.59 Million
Q4 2017

Feb 14, 2018

BUY
$24.79 - $29.8 $180,223 - $216,646
7,270 Added 5.51%
139,256 $3.45 Million
Q3 2017

Nov 13, 2017

BUY
$26.26 - $29.17 $3.47 Million - $3.85 Million
131,986
131,986 $3.85 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Cerity Partners LLC Portfolio

Follow Cerity Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.